47 related articles for article (PubMed ID: 31144726)
1. Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices.
Fett N; Haynes K; Propert KJ; Margolis DJ
J Am Acad Dermatol; 2014 Apr; 70(4):651-658. PubMed ID: 24485529
[TBL] [Abstract][Full Text] [Related]
2. Lenalidomide and risk of second primary malignancy-is disease context key?
Pawlyn C; Bird S
Lancet Haematol; 2022 Dec; 9(12):e868-e869. PubMed ID: 36457218
[No Abstract] [Full Text] [Related]
3. When a molecular signature helps to manage a case of eosinophilic dermatosis.
Chircop I; Reynaud V; Villani AP; Chastagner M
Eur J Dermatol; 2023 Oct; 33(5):573-574. PubMed ID: 38297943
[No Abstract] [Full Text] [Related]
4. Post-Zoster Eosinophilic Dermatosis and Acquired Tufted Angioma: Isotopic Response.
Kim YS; Lee YS; Han TY; Lee J; Choi JE
Indian J Dermatol; 2022; 67(5):614-615. PubMed ID: 36865826
[No Abstract] [Full Text] [Related]
5. Rethinking paraneoplastic eosinophilia.
Bernt KM
Haematologica; 2024 Apr; ():. PubMed ID: 38572550
[TBL] [Abstract][Full Text] [Related]
6. Dermatological manifestations of hematologic neoplasms. Part II: nonspecific skin lesions/paraneoplastic diseases.
de Souza PK; Amorim RO; Sousa LS; Batista MD
An Bras Dermatol; 2023; 98(2):141-158. PubMed ID: 36682966
[TBL] [Abstract][Full Text] [Related]
7. Haematologic-Related Malignancy-Induced Eosinophilic Dermatoses (He Remained): A Narrative Review.
Kar BR; Agarwal A
Indian J Dermatol; 2022; 67(2):206. PubMed ID: 36092203
[TBL] [Abstract][Full Text] [Related]
8. Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.
Maglie R; Genovese G; Solimani F; Guglielmo A; Pileri A; Portelli F; Hertl M; Marzano AV; Antiga E
Am J Clin Dermatol; 2020 Dec; 21(6):833-854. PubMed ID: 32813229
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature.
Haddad H; Sundaram S; Magro C; Gergis U
Hematol Oncol Stem Cell Ther; 2014 Jun; 7(2):90-2. PubMed ID: 24525268
[TBL] [Abstract][Full Text] [Related]
10. Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.
Sato-Sano M; Teixeira SP; Vargas JC; Baiocchi OCCG; Enokihara MMSES; Gomes EE; Batista MD
J Dermatol; 2019 Jul; 46(7):618-621. PubMed ID: 31144726
[TBL] [Abstract][Full Text] [Related]
11. Generalized Pruriginous Eruption on a Patient With Leukemia.
Núñez-Hipólito L; Moya-Martínez C; Requena L
JAMA Dermatol; 2020 Dec; 156(12):1369-1370. PubMed ID: 33112376
[No Abstract] [Full Text] [Related]
12. Eosinophilic Dermatosis of Myeloproliferative Disease in a Young Adult With Diffuse Large B-Cell Lymphoma.
Jencks A; Kiavash K; Daveluy S; Thompson AD
Am J Dermatopathol; 2019 Apr; 41(4):303-308. PubMed ID: 30252694
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilic Dermatosis of Hematologic Malignancy.
Lucas-Truyols S; Rodrigo-Nicolás B; Lloret-Ruiz C; Quecedo-Estébanez E
Actas Dermosifiliogr; 2017; 108(6):e39-e44. PubMed ID: 28342533
[TBL] [Abstract][Full Text] [Related]
14. A case of eosinophilic dermatosis of hematologic malignancy in a patient with multiple myeloma.
Two AM; Li C; Hata T
Dermatol Online J; 2014 Jan; 20(1):21256. PubMed ID: 24456959
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
